Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions.
Ceretas News
UQ ultrasound treatment for Alzheimer’s licensed to new startup
Ceretas has officially licensed a groundbreaking ultrasound technology from The University of Queensland that offers a promising non-invasive treatment for Alzheimer’s disease. Developed by UQ researchers, this technology temporarily opens the blood-brain barrier to...